肾肿瘤热消融区常规影像引导活检的检出率:11年经验
该质量改进项目评估肾细胞癌热消融后2个月常规核心活检的价值,共146/292例消融后活检。影像阴性时活检未增加信息,影像不确定时11%活检有存活肿瘤,影像阳性时仅10%检出存活肿瘤,作者认为常规活检无附加价值并已停止。
要点
- 影像阴性时活检92%为阴性,未增加额外信息。
- 影像不确定时11%活检检出存活肾细胞癌。
- 影像阳性时仅10%活检检出存活肿瘤。
核心结论
- 常规肾消融区活检验证消融后影像结果无附加价值,因此本研究机构已停止该做法。
研究设计与样本
- 质量改进项目,经机构审查委员会批准,符合健康保险携带和责任法案;2003年7月至2014年12月对肾细胞癌消融区于消融后2个月行常规核心活检,共146/292例(50%)索引消融后活检(24例冷冻消融,122例射频消融);由专科泌尿生殖病理学家行常规烟酰胺腺嘌呤二核苷酸染色评估细胞活性;影像分层为阴性、不确定或阳性,组织学分层为阴性、不确定、阳性或无法诊断。
诊断标准与关键数值
- 影像阴性(n=117)时,活检92%(n=108)阴性、0.9%(n=1)不确定、7%(n=8)无法诊断。
- 影像不确定(n=19)时,11%(n=2)活检有存活肾细胞癌、89%(n=17)阴性。
- 影像阳性(n=10)时,仅10%(1/10)活检检出存活肿瘤、80%(8/10)阴性、10%(1/10)无法诊断。
临床应用与阅片要点
- 影像阴性时常规活检未增加额外信息。
- 影像不确定时活检可检出存活肾细胞癌(11%)。
- 影像阳性时活检仅10%检出存活肿瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine the yield of routine image-guided core biopsy of renal cell carcinoma (RCC) thermal ablation zones.
METHODS: Institutional review board approval was obtained for this Health Insurance Portability and Accountability Act-compliant quality improvement effort. Routine core biopsy of RCC ablation zones was performed 2 months postablation from July 2003 to December 2014. Routine nicotinamide adenine dinucleotide staining was performed by specialized genitourinary pathologists to assess cell viability. The original purpose of performing routine postablation biopsy was to verify, in addition to imaging, whether the mass was completely treated. Imaging was stratified as negative, indeterminate, or positive for viable malignancy. Histology was stratified as negative, indeterminate, positive, or nondiagnostic for viable malignancy. Histology results were compared to prebiopsy imaging findings.
RESULTS: Routine ablation zone biopsy was performed after 50% (146/292) of index ablations (24 cryoablations, 122 radiofrequency ablations), and postablation imaging was performed more often with multiphasic computed tomography than magnetic resonance imaging (100 vs 46, p < 0.0001). When imaging was negative (n = 117), biopsy added no additional information (92% [n = 108] negative, 0.9% [n = 1] indeterminate, 7% [n = 8] nondiagnostic). When imaging was indeterminate (n = 19), 11% (n = 2) of biopsies had viable RCC and 89% (n = 17) were negative. When imaging was positive, biopsy detected viable neoplasm in only 10% (1/10) of cases; 80% (8/10) were negative and 10% (1/10) were nondiagnostic.
CONCLUSION: Routine biopsy of renal ablation zones to validate postablation imaging results was not value-added and therefore was discontinued at the study institution.
引用
- Wasnik AP, Higgins EJ, Fox GA, et al. Yield of Routine Image-Guided Biopsy of Renal Mass Thermal Ablation Zones: 11-Year Experience. Acad Radiol. 2018. PMID: 29934021. doi:10.1016/j.acra.2018.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。